Literature DB >> 3407556

Ventricular histamine concentrations in naive and morphine-treated rats during acute myocardial ischaemia.

W W Ko1, S Dai, M Y Chan.   

Abstract

The ventricular histamine concentrations of naive and morphine-treated rats subjected to acute left coronary artery ligation were examined. In naive animals, there was a significant increase in the right ventricular histamine level at 5 min following ligation, but not at 3 or 10 min. Left ventricular histamine concentrations tended to decrease, but the changes were not statistically significant. In shamoperated rats, neither acute nor chronic morphine treatment significantly altered either right or left ventricular histamine levels. Acute morphine treatment also did not significantly affect the ventricular histamine content at 5 min following coronary artery ligation. However, both right and left ventricular histamine concentrations were found to be significantly lower in chronic morphine-treated rats than in the naive animals when they were subjected to acute myocardial ischaemia. If the hypothesis that histamine release may contribute to the genesis of early ventricular arrhythmias resulting from acute myocardial ischaemia is accepted, the present findings suggest that the previously reported decreased incidence and delayed onset of early ventricular arrhythmias induced by acute left coronary artery ligation in chronic morphine-treated rats may be attributed to the reduced ventricular histamine concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3407556     DOI: 10.1007/bf01968085

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  25 in total

1.  Delayed development of ventricular ectopic rhythms following experimental coronary occlusion.

Authors:  A S HARRIS
Journal:  Circulation       Date:  1950-06       Impact factor: 29.690

2.  Ventricular histamine concentrations and arrhythmias during acute myocardial ischaemia in rats.

Authors:  S Dai
Journal:  Agents Actions       Date:  1987-06

3.  Reversibility of morphine tolerance and dependence in guinea pig brain and myenteric plexus.

Authors:  R Schulz; C Cartwright; A Goldstein
Journal:  Nature       Date:  1974-09-27       Impact factor: 49.962

4.  Effects of histamine on human isolated heart muscle: comparison with effects of noradrenaline.

Authors:  R W Gristwood; J C Lincoln; D A Owen
Journal:  J Pharm Pharmacol       Date:  1980-02       Impact factor: 3.765

5.  Histamine release during an experimental coronary thrombosis in awake dog.

Authors:  E Masini; J Phanchenault; F Pezziardi; P Gautier; J P Gagnol
Journal:  Agents Actions       Date:  1985-04

6.  Selective release of histamine from rat mast cells by several drugs.

Authors:  H V Ellis; A R Johnson; N C Moran
Journal:  J Pharmacol Exp Ther       Date:  1970-12       Impact factor: 4.030

7.  Histamine release from human right atrium.

Authors:  R W Gristwood; J C Lincoln; D A Owen; I R Smith
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

8.  Supersensitivity to noradrenaline in vas deferens from morphine-dependent mice is confirmed.

Authors:  G A Rae; S De Moraes
Journal:  Eur J Pharmacol       Date:  1983-01-21       Impact factor: 4.432

9.  Chronically administered morphine increases dopamine receptor sensitivity in mice.

Authors:  J R Martin; A E Takemori
Journal:  Eur J Pharmacol       Date:  1986-02-18       Impact factor: 4.432

10.  Relationship of stress-induced histidine decarboxylase to circulatory homeostasis and shock.

Authors:  R W SCHAYER
Journal:  Science       Date:  1960-01-22       Impact factor: 47.728

View more
  2 in total

1.  Ventricular histamine concentrations and mast cell counts in the rat heart during acute ischaemia.

Authors:  S Dai; C W Ogle
Journal:  Agents Actions       Date:  1990-03

2.  Release of histamine from isolated rat hearts during reperfusion is not dependent on length of ischemic insult, or contents of histamine in cardiac tissue.

Authors:  G Valen; J Kaszaki; I Szabo; S Nagy; J Vaage
Journal:  Agents Actions       Date:  1993-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.